Regorafenib in Patients with Solid Tumors with BRAF Alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
JCO Precision Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined